Modulation of tumor-infiltrating lymphocyte cytolytic activity against human non-small cell lung cancer

Lung Cancer

Volumn 36, Issue 1, 2002, Pages 17-25

  Ortegel, John W ^a   Staren, Edgar D ^a   Faber, L P ^a   Warren, William H ^a   Braun, Donald P ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Cytokines; Lung cancer; TGF 1; Tumor infiltrating lymphocytes

Indexed keywords

ANTIBODY; CHROMIUM 51; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 2 ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 6; MESSENGER RNA; MONOCLONAL ANTIBODY CD3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR IMMUNITY;

EID: 0036118716     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00472-X     Document Type: Article

References (38)

1. Some historical perspectives on the relationship between survival and mononuclear cell infiltration
2. Separation, phenotyping and limiting-dilution analysis of T lymphocyte infiltrating human solid tumors
3. Functional analysis of mononuclear cells infiltrating into tumors: Lysis of autologous human tumor cells by cultured infiltrating lymphocytes
4. Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site
5. Transforming growth factor-B-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in tumor-bearing state
6. Destruction of extracellular matrices containing glycoproteins elastin and collagen by metastatic human tumor cells
7. The role of IL10 in crossregulation of Th1 and Th2 responses
8. Type 1 versus type 2 cytokine release by Vβ T cell subpopulations determines in vivo anti-tumor reactivity: IL10 mediates a suppressive role
9. Human non-small cell lung cancer cells express a type 2 cytokine pattern
10. Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients
11. Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human non-small cell lung carcinoma
12. The international system for staging lung cancer
13. Genes for interleukin 7 are transcribed in leukemic cell subsets of individuals with chronic lymphocytic leukemia
14. Lymphokine-activated killer cell induction in tumor-infiltrating leukocytes from colon cancer patients
15. Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer
16. Response of primary human lung carcinomas to autocrine growth factors produced by a lung carcinoma cell line
17. Phenotypes of lymphocytes infiltrating non-small cell lung cancer tissues and its variation with histological types of cancer
18. Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin-6
19. Expression of transforming growth factor β ligand and receptor message RNAs in lung cancer cell lines
20. The transforming growth factor β family
21. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth
22. 1
23. Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α
24. Transforming growth factor β-1 modulates the expression of class II histocompatibility antigens on human cells
25. Serum levels of interleukin-6 in patients with lung cancer
26. TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC)
27. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells: Specific inhibition of IL-2 production and proliferation
28. The functional and characterization of IL-10 receptor expression on human natural killer cells
29. Stimulation of cytolytic activity by interleukin-10
30. Interleukin-10 protects target cells from tumor- and allo-specific cytotoxic T cells and down-regulates HLA class I expression
31. Interleukin-10 converts mouse lymphoma cells to a CTL resistant, NK sensitive phenotype with low but peptide inducible MHC class I expression
32. Interleukin-4: A prototypic immunoregulatory lymphokine
33. Interleukin 4 receptor expression on human lung tumors and normal lung
34. Anti-proliferative effect of human interleukin-4 in human cancer cell lines: Studies on the mechanism
35. Inhibition of colon and breast carcinoma cell growth by interleukin-4
36. Lack of effects of recombinant human interleukin-4 on in vitro colony formation of freshly explanted human tumor cells
37. Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor
38. Induction of lymphokine-activated killer activity by interleukin-4 in human lymphocytes pre-activated by interleukin-2 in vivo or in vitro